EUVIMEDEUVIMED entdecken
Open Access

[Retracted] Bone morphogenetic protein and activin membrane‑bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF‑β‑induced EMT signaling pathway

Fengsong Liu, Kai Wang, Liang Zhang, Ya-Lin Yang

Oncology Letters · 09.11.2026 · 33 (1) · 1-1

DOI: 10.3892/ol.2026.15941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 09.11.2026. Verfasst von Fengsong Liu und 3 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Liu, F., Wang, K., Zhang, L., & Yang, Y. L. (2026). [Retracted] Bone morphogenetic protein and activin membrane‑bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF‑β‑induced EMT signaling pathway. Oncology Letters, 33(1), 1-1. https://doi.org/10.3892/ol.2026.15941

Vancouver

Liu F, Wang K, Zhang L, Yang YL. [Retracted] Bone morphogenetic protein and activin membrane‑bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF‑β‑induced EMT signaling pathway. Oncology Letters. 2026;33(1):1-1. doi:10.3892/ol.2026.15941

BibTeX
@article{Liu2026,
  author = {Liu, Fengsong and Wang, Kai and Zhang, Liang and Yang, Ya-Lin},
  title = {[Retracted] Bone morphogenetic protein and activin membrane‑bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF‑β‑induced EMT signaling pathway},
  journal = {Oncology Letters},
  year = {2026},
  volume = {33},
  number = {1},
  pages = {1--1},
  doi = {10.3892/ol.2026.15941}
}
Kostenlos starten →